Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 9, 2025
Biologics in the treatment of active Psoriatic arthritis in China: a network meta-analysis and cost-effectiveness analysis
Ouyang Xie, Meiyu Wu, Andong Li, et al.
Immunotherapy
|
April 25, 2026
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis
Zixuan Zhang, Kehui Meng, Meiyu Wu, et al.
Frontiers in Pharmacology
|
May 2, 2022
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review
Meiyu Wu, Shuxia Qin, Liting Wang, et al.
Molecular Medicine Reports
|
May 13, 2017
Increased production of human fibroblast growth factor 17 in Escherichia coli and proliferative activity in NIH3T3 cells
Meiyu Wu, Na Song, Jiliang Cheng, et al.
Frontiers in Public Health
|
August 29, 2022
Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study
Shuxia Qin, Xuehong Wang, Sini Li, et al.
Clinical Rheumatology
|
February 21, 2025
Sequential biologic therapy in the treatment of active psoriatic arthritis in China: a cost-effectiveness analysis
Ouyang Xie, Meiyu Wu, Andong Li, et al.
Frontiers in Immunology
|
October 31, 2025
Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China
Meiyu Wu, Yangke Yi, Andong Li, et al.
Clinical and Molecular Hepatology
|
December 3, 2024
Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study
Meiyu Wu, Jing Ma, Xuehong Wang, et al.
Pharmacoeconomics
|
September 2, 2024
Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study
Meiyu Wu, Jing Ma, Sini Li, et al.
RSC Advances
|
May 11, 2022
Bio-distribution and bio-availability of silver and gold in rat tissues with silver/gold nanorod administration
Meiyu Wu, Liang Chen, Ruiru Li, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Expert Review of Pharmacoeconomics & Outcomes Research
|
January 9, 2025
Biologics in the treatment of active Psoriatic arthritis in China: a network meta-analysis and cost-effectiveness analysis
Ouyang Xie, Meiyu Wu, Andong Li, et al.
Immunotherapy
|
April 25, 2026
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis
Zixuan Zhang, Kehui Meng, Meiyu Wu, et al.
Frontiers in Pharmacology
|
May 2, 2022
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review
Meiyu Wu, Shuxia Qin, Liting Wang, et al.
Molecular Medicine Reports
|
May 13, 2017
Increased production of human fibroblast growth factor 17 in Escherichia coli and proliferative activity in NIH3T3 cells
Meiyu Wu, Na Song, Jiliang Cheng, et al.
Frontiers in Public Health
|
August 29, 2022
Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study
Shuxia Qin, Xuehong Wang, Sini Li, et al.
Clinical Rheumatology
|
February 21, 2025
Sequential biologic therapy in the treatment of active psoriatic arthritis in China: a cost-effectiveness analysis
Ouyang Xie, Meiyu Wu, Andong Li, et al.
Frontiers in Immunology
|
October 31, 2025
Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China
Meiyu Wu, Yangke Yi, Andong Li, et al.
Clinical and Molecular Hepatology
|
December 3, 2024
Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study
Meiyu Wu, Jing Ma, Xuehong Wang, et al.
Pharmacoeconomics
|
September 2, 2024
Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study
Meiyu Wu, Jing Ma, Sini Li, et al.
RSC Advances
|
May 11, 2022
Bio-distribution and bio-availability of silver and gold in rat tissues with silver/gold nanorod administration
Meiyu Wu, Liang Chen, Ruiru Li, et al.
Page
of 6